p73 supports cellular growth through c-Jun-dependent AP-1 transactivation

Nature Cell Biology

Volumn 9, Issue 6, 2007, Pages 698-706

  Vikhanskaya, Faina ^a   Toh, Wen Hong ^a   Dulloo, Iqbal ^a   Wu, Qiang ^b   Boominathan, Lakshmanane ^c   Ng, Huck Hui ^b,c   Vousden, Karen H ^d   Sabapathy, Kanaga ^a,c  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b GENOME INSTITUTE OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; DNA; PROTEIN C JUN; PROTEIN P53; PROTEIN P73; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 1; DNA BINDING PROTEIN; NUCLEAR PROTEIN; PROTEIN C FOS; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER CELL CULTURE; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA SEQUENCE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TRANSACTIVATION; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; CELL CULTURE; CELL STRAIN 3T3; CELL STRAIN COS1; CELL TRANSFORMATION; CERCOPITHECUS; GENETICS; METABOLISM; MOUSE MUTANT; PHOSPHORYLATION; PROTEIN BINDING; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIN D1; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, KNOCKOUT; NIH 3T3 CELLS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 34447568465     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb1598     Document Type: Article

References (30)

1. Zaika, A. I., Kovalev, S., Marchenko, N. D. & Moll, U. M. Overexpression of the wild type p73 gene in breast cancer tissues and cell lines. Cancer Res. 59, 3257-3263 (1999).
2. Concin, N. et al. Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo. Cancer Res, 64, 2449-2460 (2004).
3. Yang, A., Kaghad, M., Caput, D. & McKeon, F. On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet. 18, 90-95 (2002).
4. Melino, G., De Laurenzi, V. & Vousden, K. H. p73: Friend or foe in tumorigenesis. Nature Rev. Cancer 2, 605-615 (2002).
5. Herber, B., Truss, M., Beato, M. & Muller, R. Inducible regulatory elements in the human cyclin D1 promoter. Oncogene 9, 1295-1304 (1994).
6. Toh, W. H., Siddique, M. M., Boominathan, L, Lin, K. W. & Sabapathy, K. c-Jun regulates the stability and activity of the p53 homologue, p73. J. Biol. Chem. 279, 44713-44722 (2004).
7. Fu, M., Wang, C., Li, Z., Sakamaki, T. Pestell, R. G. Cyclin D1: Normal and abnormal functions. Endocrinology 145, 5439-5447 (2004).
8. el Deiry W. S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993).
9. Blint, E., Phillips, A. C., Kozlov, S., Stewart, C. L. & Vousden, K. H. Induction of p57(KIP2) expression by p73β. Proc. Natl Acad. Sci. USA 99, 3529-3534 (2002).
10. Pozniak, C. D. et al. An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. Science 289, 304-306 (2000).
11. Agami, R., Blandino, G., Oren, M. & Shaul, Y. Interaction of c-Abl and p73α and their collaboration to induce apoptosis. Nature 399 809-813 (1999).
12. Gaiddon, C. et al. Cyclin-dependent kinases phosphorylate p73 at threonine 86 in a cell cycle-dependent manner and negatively regulate p73. J. Biol. Chem. 278, 27421-27431 (2003).
13. Fulco, M. et al. p73 is regulated by phosphorylation at the G2/M transition. J. Biol. Chem. 278, 49196-49202 (2003).
14. Mantovani, F. et al. Pin1 links the activities of c-Abl and p300 in regulating p73 function. Mol. Cell 14, 625-636 (2004).
15. Barila, D. et al. A nuclear tyrosine phosphorylation circuit: c-Jun as an activator and substrate of c-Abl and JNK. EMBO J. 19, 273-281 (2000).
16. Angel, P. et al. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49, 729-739 (1987).
17. Matsuo, K. et al. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation. Nature Genet. 24, 184-187 (2000).
18. Cawley, S. et al. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116, 499-509 (2004).
19. Han, Z. et al. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J. Clin. Invest. 108, 73-81 (2001).
20. Behrens, A. et al. Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation. Nature Genet. 21, 326-329 (1999).
21. Zhu, J., Jiang, J., Zhou, W. & Chen, X. The potential tumor suppressor p73 differentially regulates cellular p53-target genes. Cancer Res. 58, 5061-5065 (1998).
22. Toh, W. H., Kyo S. & Sabapathy, K. Relief of p53-mediated telomerase suppression by p73. J. Biol, Chem. 280, 17329-17338 (2005).
23. Yang, A. et al. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 404, 99-103 (2000).
24. Jacks, T. et al. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4, 1-7 (1994).
25. Harvey, M. et al. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8, 2457-2467 (1993).
26. Hilberg, F. et al. c-jun is essential for normal mouse development and hepatogonesis. Nature 365, 179-181 (1993).
27. Eferl, R. et al. Functions of c-Jun in liver and heart development. J. Cell Biol. 145, 1049-1061 (1999).
28. Raivich, G. et al. The AP-1 transcription factor c-Jun is required for efficient axonal regeneration. Neuron 43, 57-67 (2004).
29. Sabapathy, K., Hochedlinger, K., Nam, S. Y, Bauer, A., Karin, M. & Wagner E. F. Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Mol. Cell 15, 713-725 (2004)
30. Passegue, E. & Wagner, E.F. JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression. EMBO J. 19 2969-2679 (2000).